Caspase-independent necrotic cell death induced by a radiosensitizer, 8-nitrocaffeine

Cancer Science

Volumn 95, Issue 4, 2004, Pages 361-366

  Naito, Mikihiko ^a   Hashimoto, Chizuko ^a   Masui, Shigeki ^b   Tsuruo, Takashi ^a,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b POLA CHEMICAL INDUSTRIES INC   (Japan)

^c CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,7 DIMETHYL 8 NITROXANTHINE; 8 NITROCAFFEINE; ANTIMYCIN A1; ANTINEOPLASTIC AGENT; CAFFEINE DERIVATIVE; CASPASE; ETOPOSIDE; FAS ANTIBODY; FAS ANTIGEN; RADIOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE; SCAVENGER; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER THERAPY; CELL DEATH; CELL HYPOXIA; CELL POPULATION; CONTROLLED STUDY; CROSS RESISTANCE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; STIMULUS RESPONSE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; ANTIMYCIN A; CAFFEINE; CASPASES; CELL DEATH; CELL HYPOXIA; CELL LINE, TUMOR; CYSTEINE PROTEINASE INHIBITORS; DRUG RESISTANCE, MULTIPLE; ETOPOSIDE; FIBROSARCOMA; FREE RADICAL SCAVENGERS; HL-60 CELLS; HUMANS; JURKAT CELLS; K562 CELLS; NECROSIS; RADIATION-SENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; U937 CELLS; XANTHINES;

EID: 1942504153     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb03216.x     Document Type: Article

References (30)

1. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17: 2941-53.
2. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000; 6: 513-9.
3. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-65.
4. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
5. Kitanaka C, Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ 1999; 6: 508-15.
6. Xiang J, Chao DT, Korsmeyer SJ. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc Natl Acad Sci USA 1996; 93: 14559-63.
7. McCarthy NJ, Whyte MK, Gilbert CS, Evan GI. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol 1997; 136: 215-27.
8. Kitanaka C, Namiki T, Noguchi K, Mochizuki T, Kagaya S, Chi S, Hayashi A, Asai A, Tsujimoto Y, Kuchino Y. Caspase-dependent apoptosis of COS-7 cells induced by Bax overexpression: differential effects of Bcl-2 and Bcl-xL on Bax-induced caspase activation and apoptosis. Oncogene 1997; 15: 1763-72.
9. Hirsch T, Marchetti P, Susin SA, Dallaporta B, Zamzami N, Marzo I, Geuskens M, Kroemer G. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 1997; 15: 1573-81.
10. Amarante-Mendes GP, Finucane DM, Martin SJ, Cotter TG, Salvesen GS, Green DR. Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death. Cell Death Differ 1998; 5: 298-306.
11. Deas O, Dumont C, MacFarlane M, Rouleau M, Hebib C, Harper F, Hirsch F, Charpentier B, Cohen GM, Senik A. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J Immunol 1998; 161: 3375-83.
12. Kawahara A, Ohsawa Y, Matsumura H, Uchiyama Y, Nagata S. Caspase-independent cell killing by Fas-associated protein with death domain. J Cell Biol 1999; 143: 1353-60.
13. Matsumura H, Shimizu Y, Ohsawa Y, Kawahara A, Uchiyama Y, Nagata S. Necrotic death pathway in Fas receptor signaling. J Cell Biol 2000; 151: 1247-56.
14. Wardman P, Clarke E, Jacobs R, Minchinton A, Stratford M, Watts M, Woodcock M, Moazzam M, Parrick J, Wallace R, Smithen C. Development of hypoxic cell radiosensitizers: the second and third generations. In: Brady L, Brady Ls, editors. Radiation sensitizers: Their use in the clinical management of cancer. New York: Masson Publishing USA Inc; 1980. p. 83-90.
15. Shimizu S, Eguchi Y, Kamiike W, Itoh Y, Hasegawa J, Yamabe K, Otsuki Y, Matsuda H, Tsujimoto Y. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res 1996; 56: 2161-6.
16. Chen Z, Naito M, Hori S, Mashima T, Yamori T, Tsuruo T. A human IAP-family gene, apollon, expressed in human brain cancer cells. Biochem Biophys Res Commun 1999; 264: 847-54.
17. Kataoka S, Naito M, Fujita N, Ishii H, Ishii S, Yamori T, Nakajima M, Tsuruo T. Control of apoptosis and growth of malignant T lymphoma cells by lymph node stromal cells. Exp Cell Res 1993; 207: 271-6.
18. Naito M, Matsuba Y, Sato S, Hirata H, Tsuruo T. MS-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models. Clin Cancer Res 2002; 8: 582-8.
19. Kataoka S, Naito M, Tomida A, Tsuruo T. Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells. Exp Cell Res 1994; 215: 199-205.
20. Tzung SP, Kim KM, Basanez G, Giedt CD, Simon J, Zimmerberg J, Zhang KY, Hockenbery DM. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nat Cell Biol 2001; 3: 183-91.
21. Rauth AM, Melo T, Misra V. Bioreductive therapies: an overview of drugs and their mechanisms of action. Int J Radiat Oncol Biol Phys 1998; 42: 755-62.
22. Brezden CB, Horn L, McClelland RA, Rauth AM. Oxidative stress and 1-methyl-2-nitroimidazole cytotoxicity. Biochem Pharmacol 1998; 56: 335-44.
23. Liu H, Nishitoh H, Ichijo H, Kyriakis JM. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol 2000; 20: 2198-208.
24. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2001; 2: 222-8.
25. Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell 1991; 65: 1097-8.
26. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994; 78: 539-42.
27. Noguchi K, Naito M, Kataoka S, Yonehara S, Tsuruo T. A recessive mutant of the U937 cell line acquired resistance to anti-Fas and anti-p55 tumor necrosis factor receptor antibody-induced apoptosis. Cell Growth Differ 1995; 6: 1271-7.
28. Noguchi K, Naito M, Oshimura M, Mashima T, Fujita N, Yonehara S, Tsuruo T. Chromosome 22 complements apoptosis in Fas- and TNF-resistant mutant UK110 cells. Oncogene 1996; 13: 39-46.
29. Dong J, Naito M, Mashima T, Jang WH, Tsuruo T. Genetically recessive mutant of human monocytic leukemia U937 resistant to tumor necrosis factor-alpha-induced apoptosis. J Cell Physiol 1998; 174: 179-85.
30. Dong J, Naito M, Tsuruo T. c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells. Oncogene 1997; 15: 639-47.